ALPHA TRIBE

Hindustan Bio Sciences LtdBoard Meeting, 30-05-2026: Board Meeting

30-05-2026 | 06:50 pm

Hindustan Biosciences board approved Q4 results, posting a loss of ₹0.12 Cr. For FY26, revenue was ₹0.74 Cr, with a net loss of ₹0.08 Cr. Mr. GBK Viswanadham was appointed Internal Auditor. Equity capital stands at ₹2.05 Cr.

No comments yet. Be the first to comment!

All announcements from Hindustan Bio Sciences Ltd